Announcements Trials
Browse Landscape

Phase

Phase NA 14Phase 2 2Phase 3 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 1Heart Diseases 1Colonic Polyps 1Colonic Neoplasms 1Adenoma 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 282Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Completed × Mass Screening × Clear all
NCT01714271 2023-10-02

Promotora-based Latino Family CVD Risk Reduction

University of California, Los Angeles

Phase 2 Completed
204 enrolled

Heart Diseases, Neoplasms

NCT01549535 2016-11-25

Polyp Detection With The Peerscope Systemâ„¢

PeerMedical Ltd.

Phase 2 Completed
197 enrolled
Gastrointestinal

Adenoma, Colonic Neoplasms, Colonic Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡